Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Zoetis (NY: ZTS )

176.96 +0.25 (+0.14%)
Official Closing Price Updated: 7:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Zoetis

< Previous 1 2
...
9 10 11 12 13 14 15 16 Next >
Zoetis to Host Webcast and Conference Call on Fourth Quarter and Full Year 2021 Financial Results
From Zoetis Inc.
Via Business Wire
Price To Earnings Ratio Insights For Zoetis
In the current session, Zoetis Inc. (NYSE:ZTS) is trading at $229.83, after a 1.83% increase. Over the past month, the stock increased by 6.13%, and in the past year... 
Via Benzinga
Zoetis Raises FY22 Dividend By 30%, Announces New Buyback Program Of $3.5B
The board of directors of Zoetis Inc (NYSE: ZTS) has approved a $3.5 billion share repurchase program. The company added that the new share buyback, spanning... 
Via Benzinga
Zoetis Announces Authorization of $3.5 Billion Share Repurchase Program
From Zoetis Inc.
Via Business Wire
The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4) Absci, CORP (NASDAQ: ABSI) (... 
Via Benzinga
Zoetis Named One of Newsweek’s Most Responsible Companies for 2022
From Zoetis Inc.
Via Business Wire
Here's How Much You Would Have Made Owning Zoetis Stock In The Last 5 Years
Zoetis (NYSE:ZTS) has outperformed the market over the past 5 years by 19.02% on an annualized basis. Buying $100.00 In ZTS: 5 years ago, an investor could have purchased 2.01... 
Via Benzinga
The ProShares Pet Care ETF Capitalizes on Our Love for Our Pets
Our little furry friends are part of an industry projected to be worth $350 billion by 2027. That's where the PAWZ ETF comes in. 
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For November 18, 2021
Upgrades Macquarie upgraded the previous rating for ZTO Express (Cayman) Inc (NYSE: 
Via Benzinga
Zoetis inc (ZTS) Q3 2021 Earnings Call Transcript
ZTS earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Zoetis Extends Its Breakout As Fido's Drugmaker Beats Quarterly Forecasts
Zoetis also issued better-than-expected guidance for 2021. 
Via Investor's Business Daily
Zoetis Announces Third Quarter 2021 Results
From Zoetis Inc.
Via Business Wire
Earnings Scheduled For November 4, 2021
Companies Reporting Before The Bell • DISH Network (NASDAQ:DISH) is likely to report quarterly earnings at $0.91 per share on revenue of $4.45 billion. • Cars.com... 
Via Benzinga
Zoetis Announces Appointment of Robert J. Polzer, PhD, as President of Research & Development for World Leader in Animal Health
From Zoetis Inc.
Via Business Wire
Zoetis Declares Fourth Quarter 2021 Dividend
From Zoetis Inc.
Via Business Wire
Zoetis to Host Webcast and Conference Call on Third Quarter 2021 Financial Results
From Zoetis Inc.
Via Business Wire
Zoetis Named a “100 Best Company” and a “Best Company for Dads” by Seramount
From Zoetis Inc.
Via Business Wire
Cramer Weighs In On Lennar, Alibaba And More
On CNBC's "Mad Money Lightning Round," Jim Cramer said he needs something less speculative than Original BARK Co (NYSE: BARK). He suggested Zoetis Inc (NYSE: ZTS),... 
Via Benzinga
4 Top Healthcare Stocks to Buy in September
In addition to playing a major role in helping the world fight the COVID-19 pandemic, the healthcare industry is making solid progress in addressing the rising health issues faced by an aging global... 
Via Talk Markets
Exposures COVID-19
Zoetis to Participate in the Jefferies Virtual Pet Care Summit
From Zoetis Inc.
Via Business Wire
'Fast Money Halftime Report' Picks For September 8
On CNBC's "Fast Money Halftime Report," Jon Najarian said the October $65 calls and the October $70 calls in Bristol-Myers Squibb Co (NYSE: BMY) were extremely... 
Via Benzinga
The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 2) Abbott Laboratories (NYSE:... 
Via Benzinga
10 Biggest Price Target Changes For Monday
Jefferies raised the price target on Tesla, Inc. (NASDAQ: 
Via Benzinga
Zoetis inc (ZTS) Q2 2021 Earnings Call Transcript
ZTS earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
The Daily Biotech Pulse: Cara's Korsuva Greenlighted By FDA, Clinical Trial Disappointments For Novartis, Theravance, Vertex Inks CRISPR Licensing Deal
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 23) AbbVie Inc. (NYSE: ABBV) (... 
Via Benzinga
Exposures Product Safety
Zoetis Earnings Top Views For Animal-Health Giant
Zoetis exceeded Q2 earnings and revenue estimates. Shares of the animal-health giant were little changed. 
Via Investor's Business Daily
Zoetis Announces Second Quarter 2021 Results
From Zoetis Inc.
Via Business Wire
Stocks That Hit 52-Week Highs On Friday
Before 10 a.m. ET on Friday, 52 companies hit new 52-week highs. Highlights: Microsoft (NASDAQ:MSFT) was the biggest company by market cap to set a new 52-week high... 
Via Benzinga
The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 19) Alkermes plc (NASDAQ: ALKS... 
Via Benzinga
Exposures COVID-19
Earnings Scheduled For August 5, 2021
Companies Reporting Before The Bell • OneSpaWorld Holdings (NASDAQ:OSW) is projected to report quarterly loss at $0.20 per share on revenue of $6.42 million. •... 
Via Benzinga
< Previous 1 2
...
9 10 11 12 13 14 15 16 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.